BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Langenberg DR, Lange K, Hetzel DJ, Holtmann GJ, Andrews JM. Adverse clinical phenotype in inflammatory bowel disease: A cross sectional study identifying factors potentially amenable to change: Factors associated with adverse IBD outcomes. Journal of Gastroenterology and Hepatology 2010;25:1250-8. [DOI: 10.1111/j.1440-1746.2010.06302.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Mikocka-walus A, Fielder A, Prady SL, Esterman AJ, Knowles S, Andrews JM; Cochrane IBD Group. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012680] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Sack C, Phan VA, Grafton R, Holtmann G, van Langenberg DR, Brett K, Clark M, Andrews JM. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. J Crohns Colitis. 2012;6:302-310. [PMID: 22405166 DOI: 10.1016/j.crohns.2011.08.019] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
3 Phan VH, van Langenberg DR, Grafton R, Andrews JM. A dedicated inflammatory bowel disease service quantitatively and qualitatively improves outcomes in less than 18 months: a prospective cohort study in a large metropolitan centre. Frontline Gastroenterol 2012;3:137-42. [PMID: 28839654 DOI: 10.1136/flgastro-2011-100086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
4 Zittan E, Gralnek IM, Berns MS. The New Proactive Approach and Precision Medicine in Crohn's Disease. Biomedicines 2020;8:E193. [PMID: 32635316 DOI: 10.3390/biomedicines8070193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Graff LA, Fowler S, Jones JL, Benchimol EI, Bitton A, Huang JG, Kuenzig ME, Kaplan GG, Lee K, Mukhtar MS, Tandon P, Targownik LE, Windsor JW, Bernstein CN. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life. J Can Assoc Gastroenterol 2021;4:S46-53. [PMID: 34755039 DOI: 10.1093/jcag/gwab031] [Reference Citation Analysis]
6 Mikocka-Walus A, Pittet V, Rossel JB, von Känel R. Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2016;14:829-835.e1. [PMID: 26820402 DOI: 10.1016/j.cgh.2015.12.045] [Cited by in Crossref: 160] [Cited by in F6Publishing: 145] [Article Influence: 26.7] [Reference Citation Analysis]
7 Philippou A, Sehgal P, Ungaro RC, Wang K, Bagiella E, Dubinsky MC, Keefer L. High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab200. [PMID: 34448855 DOI: 10.1093/ibd/izab200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Burger D, Travis S. Conventional Medical Management of Inflammatory Bowel Disease. Gastroenterology 2011;140:1827-1837.e2. [DOI: 10.1053/j.gastro.2011.02.045] [Cited by in Crossref: 135] [Cited by in F6Publishing: 120] [Article Influence: 12.3] [Reference Citation Analysis]
9 Mikocka-Walus AA, Turnbull D, Holtmann G, Andrews JM. An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementation. Inflamm Bowel Dis. 2012;18:1573-1581. [PMID: 22179943 DOI: 10.1002/ibd.22850] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
10 Mikocka-Walus A, Power M, Rook L, Robins G; CCUK York Walk Planning Committee. What Do Participants of the Crohn's and Colitis UK (CCUK) Annual York Walk Think of Their Inflammatory Bowel Disease Care? A Short Report on a Survey. Gastroenterol Nurs 2018;41:59-64. [PMID: 28002076 DOI: 10.1097/SGA.0000000000000261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Vasudevan A, Arachchi A, van Langenberg DR. Assessing patient satisfaction in inflammatory bowel disease using the QUOTE-IBD survey: a small step for clinicians, a potentially large step for improving quality of care. J Crohns Colitis. 2013;7:e367-e374. [PMID: 23528836 DOI: 10.1016/j.crohns.2013.02.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
12 Tavakoli P, Vollmer-Conna U, Hadzi-Pavlovic D, Grimm MC. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public Health Rev 2021;42:1603990. [PMID: 34692176 DOI: 10.3389/phrs.2021.1603990] [Reference Citation Analysis]
13 Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:752-762. [PMID: 26841224 DOI: 10.1097/mib.0000000000000620] [Cited by in Crossref: 225] [Cited by in F6Publishing: 95] [Article Influence: 37.5] [Reference Citation Analysis]
14 Glynn H, Knowles SR. A Phenomenological Investigation of Trauma in 18 Adults Living With Inflammatory Bowel Disease. Clin Nurs Res. [DOI: 10.1177/10547738221075649] [Reference Citation Analysis]
15 Greywoode R, Ullman T, Keefer L. National Prevalence of Psychological Distress and Use of Mental Health Care in Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac050. [PMID: 35325138 DOI: 10.1093/ibd/izac050] [Reference Citation Analysis]
16 Lee JW. Anxiety and Depression in Patients with Inflammatory Bowel Diseases: The First Step toward Proper Management. Gut Liver 2020;14:395-6. [PMID: 32655016 DOI: 10.5009/gnl20187] [Reference Citation Analysis]
17 Tan M, Holloway RH, Lange K, Andrews JM. General practitioners' knowledge of and attitudes to inflammatory bowel disease: GPs' IBD knowledge and comfort. Internal Medicine Journal 2012;42:801-7. [DOI: 10.1111/j.1445-5994.2011.02586.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
18 Morrison G, Van Langenberg DR, Gibson SJ, Gibson PR. Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort. Inflamm Bowel Dis. 2013;19:1210-1217. [PMID: 23524595 DOI: 10.1097/mib.0b013e318280e729] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]
19 Mattar M, Duong N, Hussain N, Kallus S, Som A. Inflammatory bowel disease (IBD) activity and depression. GHOA 2018;9. [DOI: 10.15406/ghoa.2018.09.00316] [Reference Citation Analysis]
20 Mikocka-Walus A, Prady SL, Pollok J, Esterman AJ, Gordon AL, Knowles S, Andrews JM. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database Syst Rev 2019;4:CD012680. [PMID: 30977111 DOI: 10.1002/14651858.CD012680.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tribbick D, Salzberg M, Ftanou M, Connell WR, Macrae F, Kamm MA, Bates GW, Cunningham G, Austin DW, Knowles SR. Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohort. Clin Exp Gastroenterol 2015;8:197-204. [PMID: 26213474 DOI: 10.2147/CEG.S77567] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
22 Bakir-gungor B, Hacılar H, Jabeer A, Nalbantoglu OU, Aran O, Yousef M. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods. PeerJ 2022;10:e13205. [DOI: 10.7717/peerj.13205] [Reference Citation Analysis]
23 Mikocka-Walus A, Massuger W, Knowles SR, Moore GT, Buckton S, Connell W, Pavli P, Raven L, Andrews JM. Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes. JGH Open 2020;4:166-71. [PMID: 32280760 DOI: 10.1002/jgh3.12236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
24 Raman M, Rajagopalan V, Kaur S, Reimer RA, Ma C, Ghosh S, Vallance J. Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review. Inflamm Bowel Dis 2021:izab218. [PMID: 34605548 DOI: 10.1093/ibd/izab218] [Reference Citation Analysis]
25 Langenberg DRV, Andrews JM. Satisfaction with patient-doctor relationships in inflammatory bowel diseases: Examining patient-initiated change of specialist. World J Gastroenterol 2012; 18(18): 2212-2218 [PMID: 22611314 DOI: 10.3748/wjg.v18.i18.2212] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
26 Mikocka-walus AA, Andrews JM, Bernstein CN, Graff LA, Walker JR, Spinelli A, Danese S, van der Woude JC, Goodhand J, Rampton D, Moser G. Integrated Models of Care in Managing Inflammatory Bowel Disease: A Discussion: . Inflammatory Bowel Diseases 2012;18:1582-7. [DOI: 10.1002/ibd.22877] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
27 Mikocka-Walus A, Bampton P, Hetzel D, Hughes P, Esterman A, Andrews JM. Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial. Int J Behav Med. 2017;24:127-135. [PMID: 27432441 DOI: 10.1007/s12529-016-9580-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
28 Weaver E, Szigethy E. Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist. Curr Gastroenterol Rep 2020;22:20. [PMID: 32185521 DOI: 10.1007/s11894-020-0757-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
29 Fairbrass KM, Lovatt J, Barberio B, Yuan Y, Gracie DJ, Ford AC. Bidirectional brain-gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut 2021:gutjnl-2021-325985. [PMID: 34725197 DOI: 10.1136/gutjnl-2021-325985] [Reference Citation Analysis]
30 Siebenhüner AR, Rossel JB, Schreiner P, Butter M, Greuter T, Krupka N, Jordi SBU, Biedermann L, Rogler G, Misselwitz B, von Känel R. Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis. Therap Adv Gastroenterol 2021;14:17562848211033763. [PMID: 34484421 DOI: 10.1177/17562848211033763] [Reference Citation Analysis]
31 Caplan RA, Maunder RG, Stempak JM, Silverberg MS, Hart TL. Attachment, Childhood Abuse, and IBD-related Quality of Life and Disease Activity Outcomes: . Inflammatory Bowel Diseases 2014;20:909-15. [DOI: 10.1097/mib.0000000000000015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 2.1] [Reference Citation Analysis]
32 Mikocka-walus A, Andrews JM. Experience With and Attitudes Toward Psychotherapy and Antidepressants Among Patients With Inflammatory Bowel Disease and Functional Gastrointestinal Disorders: An Online Patient Survey to Inform System Design. Gastroenterology Nursing 2016;39:278-86. [DOI: 10.1097/sga.0000000000000182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]